# Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain

> **NCT02000388** · PHASE4 · UNKNOWN · sponsor: **Citrus Valley Medical Research, Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Post Vasectomy Pain

## Interventions

- **DRUG:** Ketorolac Tromethamine
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT02000388
- **Lead sponsor:** Citrus Valley Medical Research, Inc.
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-02
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2013-12-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02000388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02000388, "Intranasal Ketorolac Tromethamine (SPRIX) as a Short Term Pain Management of Post-Vasectomy Pain". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02000388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*